CIC
DFTX

Cornercap Investment Counsel’s Definium Therapeutics DFTX Stock Holding History

Cornercap Investment Counsel’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-56,957
Closed -$208K – 647
2023
Q4 		$208K Hold
56,957
– – 0.03% 527
2023
Q3 		$178K Buy
56,957
+479
+0.8% +$1.97K 0.03% 498
2023
Q2 		$202K Buy
+56,478
New +$195K 0.04% 511

Other funds holding DFTX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
ABG
Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Cornercap Investment Counsel's DFTX Position: Q1 2024 in Review

Cornercap Investment Counsel sold out of Definium Therapeutics (DFTX) in Q1 2024, closing a stake of 56,957 shares — an estimated $208K sold.

Cornercap Investment Counsel first reported a position in DFTX in Q2 2023 and held it in 3 quarters. The position peaked at $208K in Q4 2023. 135 funds tracked by Wall St. Rank hold DFTX as of Q1 2024.

  • Cornercap Investment Counsel reported no remaining Definium Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Cornercap Investment Counsel sold 56,957 Definium Therapeutics shares in Q1 2024, an estimated $208K.
  • Cornercap Investment Counsel first reported a position in Definium Therapeutics in Q2 2023 and held it in 3 quarters.
  • Cornercap Investment Counsel's Definium Therapeutics position peaked at $208K in Q4 2023.
  • 135 funds tracked by Wall St. Rank held Definium Therapeutics as of Q1 2024.

Based on Cornercap Investment Counsel's 13F filing for Q1 2024, filed 10 May 2024.